MODERATE-TO-SEVERE ASTHMA
Clinical trials for MODERATE-TO-SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new MODERATE-TO-SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for MODERATE-TO-SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New asthma pill shows promise in early trial for stubborn symptoms
Disease control Not yet recruitingThis study tests a new drug called linvemastat for adults with moderate-to-severe asthma that is not fully controlled by standard inhalers. The drug targets an enzyme linked to lung inflammation. About 135 participants will receive either a low dose, high dose, or placebo for 16 …
Matched conditions: MODERATE-TO-SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 03:54 UTC
-
New asthma injection shows promise in phase 2 trial
Disease control Not yet recruitingThis study tests an experimental drug called RC1416 in adults with moderate to severe asthma that is not well controlled. The goal is to see if it can improve lung function and reduce asthma attacks. About 195 participants will receive either the drug or a placebo, and researcher…
Matched conditions: MODERATE-TO-SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:40 UTC